Metabolic genetic polymorphisms and susceptibility to lung cancer

被引：36

作者：

Bouchardy, C

Benhamou, S

Jourenkova, N

Dayer, P

Hirvonen, A

机构：

[1] Geneva Canc Registry, CH-1205 Geneva, Switzerland

[2] Inst Gustave Roussy, Canc Epidemiol Unit, INSERM U521, Villejuif, France

[3] Univ Hosp Geneva, Div Clin Pharmacol, Geneva, Switzerland

[4] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki, Finland

来源：

LUNG CANCER | 2001年 / 32卷 / 02期

关键词：

lung cancer; carcinogen; metabolism; enzyme; genotype; polymorphism; tobacco consumption; epidemiology;

D O I：

10.1016/S0169-5002(00)00215-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Activity of some enzymes implicated in the metabolism of tobacco carcinogens presents a great variability between individuals due to the existence of a polymorphism in gene coding for these enzymes. Individual susceptibility to develop lung cancer could therefore depend not only on exposure to tobacco smoking, but also on genetic capacity to activate or inactivate tobacco carcinogens. This article summarizes the state of knowledge on metabolic polymorphisms and lung cancer susceptibility, and opens the discussion on the future direction of this promising way of research. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：109 / 112

页数：4

共 50 条

[1] Genetic polymorphisms and lung cancer susceptibility: a review
Kiyohara, C
Otsu, A
Shirakawa, T
Fukuda, S
Hopkin, JM
LUNG CANCER, 2002, 37 (03) : 241 - 256
[2] Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
P. Mota
H. C. Silva
M. J. Soares
A. Pego
M. Loureiro
C. Robalo Cordeiro
F. J. Regateiro
Journal of Cancer Research and Clinical Oncology, 2015, 141 : 851 - 860
[3] Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
Mota, P.
Silva, H. C.
Soares, M. J.
Pego, A.
Loureiro, M.
Robalo Cordeiro, C.
Regateiro, F. J.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 851 - 860
[4] Lung Cancer Susceptibility and Genetic Polymorphisms of Exo1 Gene in Taiwan
Hsu, Nan-Yung
Wang, Hwei-Chung
Wang, Chung-Hsing
Chiu, Chang-Fang
Tseng, Hsien-Chang
Liang, Shiu-Yun
Tsai, Chia-Wen
Lin, Cheng-Chieh
Bau, Da-Tian
ANTICANCER RESEARCH, 2009, 29 (02) : 725 - 730
[5] Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China
Chen, Han-chun
Cao, Yan-fei
Hu, Wei-xin
Liu, Xin-fa
Liu, Qing-xia
Zhang, Ji
Liu, Jia
DISEASE MARKERS, 2006, 22 (03) : 141 - 152
[6] Correlation between survivin genetic polymorphisms and lung cancer susceptibility
Guo, Guifang
Zhang, Qiang
Yu, Zhengang
Li, Junjuan
Ding, Zhaolei
Li, Juan
Tan, Wei
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7426 - 7430
[7] Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility
Eaton, Keith D.
Romine, Perrin E.
Goodman, Gary E.
Thornquist, Mark D.
Barnett, Matt J.
Petersdorf, Effie W.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 649 - 659
[8] Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility
Yang, Mihi
Choi, Yunhee
Hwangbo, Bin
Lee, Jin Soo
LUNG CANCER, 2007, 57 (02) : 135 - 142
[9] The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility
Chen, Guan-Liang
Shen, Te-Chun
Chang, Wen-Shin
Tsai, Chia-Wen
Li, Hsin-Ting
Chuang, Chih-Liang
Lai, Yi-Liang
Yueh, Te-Cheng
Hsia, Te-Chun
Wang, Shou-Cheng
Bau, Da-Tian
ANTICANCER RESEARCH, 2018, 38 (10) : 5671 - 5677
[10] The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan
Chen, Guan-Liang
Wang, Shou-Cheng
Huang, Wei-Chien
Chang, Wen-Shin
Tsai, Chia-Wen
Li, Hsin-Ting
Shen, Te-Chun
Hsia, Te-Chun
Bau, Da-Tian
ANTICANCER RESEARCH, 2019, 39 (10) : 5375 - 5380

← 1 2 3 4 5 →